Time For A New Deal For Medicine; EPHA Forum Challenges Status Quo On Medicines Policy 14/11/2019 Grace Ren The debate around drug price transparency was a highlight of the 4th Forum on Access to Medicines in Europe, hosted by the European Public Health Alliance (EPHA) Thursday. The forum focused its discussions around cancer therapies, medicines shortages, and transparency around R&D costs. “It is high time to challenge the status quo on medicines policy […] Continue reading -> Medicines for Malaria Venture At 20 Years: A Perfect Moment For New Innovation 11/11/2019 Elaine Ruth Fletcher MMV CEO David Reddy talks about the steps MMV is taking to support a new generation of malaria research leadership, promote more gender-sensitive malaria treatment and fast-track innovation on new malaria combination therapies. This follows a string of MMV successes over the past two decades in fostering new paediatric malaria treatments, new combination therapies to […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> ‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Medicines for Malaria Venture At 20 Years: A Perfect Moment For New Innovation 11/11/2019 Elaine Ruth Fletcher MMV CEO David Reddy talks about the steps MMV is taking to support a new generation of malaria research leadership, promote more gender-sensitive malaria treatment and fast-track innovation on new malaria combination therapies. This follows a string of MMV successes over the past two decades in fostering new paediatric malaria treatments, new combination therapies to […] Continue reading -> Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> ‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Non-Profit R&D Can Successfully Bring New Treatments For Neglected Diseases To Market 30/10/2019 Grace Ren Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading -> Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> ‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lessons Learned And Challenges Ahead: DNDi Celebrates 15 Years 30/10/2019 Elaine Ruth Fletcher Berlin, Germany – The Drugs for Neglected Diseases Initiative (DNDi) is celebrating its 15th anniversary and in a special event Tuesday night, founders and supporters of the product development partnership (PDP) gathered in Berlin to reflect on lessons learned and challenges that still lie ahead. Here below are excerpts of what they had to say. […] Continue reading -> Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> ‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Eight New Treatments For World’s Most Neglected Diseases: DNDi’s Pécoul Reflects On Milestones At 15 Year Mark 30/10/2019 Elaine Ruth Fletcher The Drugs for Neglected Diseases Initiative (DNDi) celebrates its 15th anniversary this week, as a non-profit drug R&D organization that sought to create an alternative model for developing drug treatments for the most neglected diseases and the world’s poorest populations. Since DNDi’s launch in 2003, the organization has developed eight new treatments, including the first-ever […] Continue reading -> ‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘Global Health Progress’ Knowledge Hub Highlights Public-Private Initiatives On Health-Related SDGs 25/10/2019 Press release A new knowledge hub Global Health Progress, highlighting over 200 collaborations between the biopharmaceutical industry involving more than 850 government, multilateral organization and civil society partners, was launched Friday by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA). The hub provides a worldwide mapping of health-related initiatives in which IFPMA members are engaged, searchable […] Continue reading -> Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> Posts navigation Older postsNewer posts